RT @89089314: フィブラート系の心血管疾患一次予防についてのコクランSR。まあRRは有意に下がるけどARRは1%以下って...... Fibrates for primary prevention of cardiovascular disease events.…
フィブラート系の心血管疾患一次予防についてのコクランSR。まあRRは有意に下がるけどARRは1%以下って...... Fibrates for primary prevention of cardiovascular disease events. - PubMed - NCBI https://t.co/bQTWzsv9kf
Fibrates for primary prevention of cardiovascular disease events. - PubMed - NCBI https://t.co/5Fr48QlY2S
Fibrates for primary prevention of cardiovascular disease events. - PubMed - NCBI https://t.co/iOFFKAnhVI フィブラートといえばこれでしょう.
RT @cochrane_russia: Фибраты у пациентов без установленных сердечно-сосудистых заболеваний: https://t.co/zxBFZc18RN https://t.co/bpGObu6Fin
[Cohrane] Fibrates for primary prevention of cardiovascular disease events https://t.co/J9qY3jgpCe
Fibratos para los pacientes sin enfermedades cardiovasculares establecidas Cochrane https://t.co/fYju8V3edQ
Fibrates for patients without established cardiovascular disease https://t.co/iKjKnL9oci from Cochrane reviews
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
RT @Mitotatu: Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.…
Fibrates for primary prevention of cardiovascular disease events - The Cochrane Library @SEMERGENap @vic_pallares https://t.co/WRBE1ha3Vx
Los fibratos reducen el riesgo de problemas cardiovasculares en prevención primaria ligeramente, pero no mortalidad. https://t.co/q3X0YmnfK8
RT @FarmaciaOesteAP: (Cochrane) Fibratos en prevención primaria de enfermedad CV: eficacia modesta https://t.co/gWol9eCynL
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @rincondesisifo: (Cochrane) Fibratos en prevención 1ª CV https://t.co/WNpsKuoQnC ↓impacto en eventos, nulo en mortalidad
Fibrates for patients without established cardiovascular disease https://t.co/XSHu5moBgr
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @FarmaciaOesteAP: (Cochrane) Fibratos en prevención primaria de enfermedad CV: eficacia modesta https://t.co/gWol9eCynL
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @CochraneUK: Moderate quality #CochraneEvidence shows fibrates lower risk of cardiovascular disease events @CochraneHeart @TheBHF https:…
RT @CochraneUK: Moderate quality #CochraneEvidence shows fibrates lower risk of cardiovascular disease events @CochraneHeart @TheBHF https:…
RT @CochraneUK: Moderate quality #CochraneEvidence shows fibrates lower risk of cardiovascular disease events @CochraneHeart @TheBHF https:…
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @FarmaciaOesteAP: (Cochrane) Fibratos en prevención primaria de enfermedad CV: eficacia modesta https://t.co/gWol9eCynL
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @RichardLehman1: By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
By less than 1%, no effect on overall mortality. https://t.co/AKayuTforJ
RT @rincondesisifo: (Cochrane) Fibratos en prevención 1ª CV https://t.co/WNpsKuoQnC ↓impacto en eventos, nulo en mortalidad
(Cochrane) Fibratos en prevención primaria de enfermedad CV: eficacia modesta https://t.co/gWol9eCynL
(Cochrane) Fibratos en prevención 1ª CV https://t.co/WNpsKuoQnC ↓impacto en eventos, nulo en mortalidad
Cochrane review on Fibrates monotherapy in primary preventions shows mixed results based on poor quality of trials. https://t.co/6AVVcSaLQd
RT @CochraneHeart: New review: fibrates lower the risk for cardiovascular and coronary events in primary prevention https://t.co/SepOwoxuiX
RT @CochraneHeart: New review: fibrates lower the risk for cardiovascular and coronary events in primary prevention https://t.co/SepOwoxuiX
RT @CochraneHeart: New review: fibrates lower the risk for cardiovascular and coronary events in primary prevention https://t.co/SepOwoxuiX
RT @CochraneHeart: New review: fibrates lower the risk for cardiovascular and coronary events in primary prevention https://t.co/SepOwoxuiX
RT @CochraneHeart: New review: fibrates lower the risk for cardiovascular and coronary events in primary prevention https://t.co/SepOwoxuiX
New review: fibrates lower the risk for cardiovascular and coronary events in primary prevention https://t.co/SepOwoxuiX